1. India Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Lupin Limited

Lupin Limited

LUPIN.NS
Lupin LimitedIN flagNational Stock Exchange of India
2,491.60
INR
+15.60
- -
1.14TMarket Cap

Total Valuation

Lupin Limited carries a market capitalization of 1.14T, placing it among publicly traded companies globally. Its enterprise value stands at 884.17B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap1.14T
Enterprise Value884.17B

Valuation Ratios

Lupin Limited trades at a trailing price-to-earnings ratio of 23.90.

PE Ratio23.90
PS Ratio3.87
PB RatioN/A
P/TBV RatioN/A
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, Lupin Limited trades at an EV/EBITDA multiple of 14.10 and an EV/FCF ratio of 330.83. The EV/Sales ratio of 3.87 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 14.10 provides insight into valuation relative to core operating earnings.

EV / Sales3.87
EV / EBITDA14.10
EV / EBIT14.10
EV / FCF330.83

Financial Position

Lupin Limited maintains a current ratio of 3.75, meaning it holds 3.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 53.40, indicating elevated leverage, while an interest coverage ratio of 19.69 demonstrates strong ability to service its debt obligations.

Current Ratio3.75
Quick Ratio0.78
Debt / Equity53.40
Debt / EBITDAN/A
Interest Coverage19.69

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)N/A
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)91.03
Revenue Per EmployeeN/A
Employee CountN/A
Inventory TurnoverN/A

Taxes

Over the trailing twelve months, Lupin Limited has paid 7.15B in income taxes, reflecting an effective tax rate of 16.12.

Income Tax7.15B
Effective Tax Rate16.12

Stock Price Statistics

Lupin Limited's stock has gained approximately 25.92742% over the past 52 weeks. The 50-day moving average sits at 2,310.39, while the 200-day moving average is 2,187.32.

Beta (5Y)N/A
52-Week Price Change25.92742%
50-Day Moving Average2,310.39
200-Day Moving Average2,187.32
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Lupin Limited generated 228.42B in revenue and converted that into 36.99B in net income, yielding earnings per share of 81.32. EBITDA reached 62.73B, while operating income came in at 62.73B.

Revenue228.42B
Gross Profit159.72B
Operating Income62.73B
Pretax Income44.38B
Net Income36.99B
EBITDA62.73B
EBIT62.73B
Earnings Per Share (EPS)81.32

Margins

Lupin Limited operates with a gross margin of 69.92, reflecting its pricing power and cost economics. The operating margin of 27.46 and net profit margin of 16.20 provide insight into operational efficiency.

Gross Margin69.92
Operating Margin27.46
Pretax Margin19.43
Profit Margin16.20
EBITDA Margin27.46

Stock Splits

Lupin Limited's most recent stock split took place on August 27, 2010 with a 1:5 split ratio.

Last Split Date8/27/2010
Split Ratio1:5

Scores

Lupin Limited posts an Altman Z-Score of 15.39, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score15.39